Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CBP-1018 by Coherent Biopharma for Bone Metastasis: Likelihood of Approval
CBP-1018 is under clinical development by Coherent Biopharma and currently in Phase I for Bone Metastasis. According to GlobalData, Phase...